Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessary.
D'Ottavi M, Godfrey-Faussett P, Merle CS, Sofonea MT, Laureillard D, Vickerman P, Molès JP, Altice FL, Van de Perre P, Stone J, Nagot N. D'Ottavi M, et al. Among authors: nagot n. Lancet Glob Health. 2025 Jan 22:S2214-109X(24)00481-9. doi: 10.1016/S2214-109X(24)00481-9. Online ahead of print. Lancet Glob Health. 2025. PMID: 39862874 Free article. Review.
Barriers and facilitators of a large clinical trial on prevention of HIV transmission through breastfeeding in Lusaka, Zambia: a qualitative study.
Mennecier A, Matoka B, Wilfred-Tonga MM, Chunda-Liyoka C, Mwiya M, Nagot N, Molès JP, Van de Perre P, Kankasa C, King R; PROMISE-EPI social science sub-study group. Mennecier A, et al. Among authors: nagot n. BMC Public Health. 2024 Dec 2;24(1):3356. doi: 10.1186/s12889-024-20855-5. BMC Public Health. 2024. PMID: 39623353 Free PMC article.
Combination of serological and cytokine release assays for improved diagnosis of childhood tuberculosis in Zambia (PROMISE-TB).
Tuaillon E, Mwyia M, Bollore K, Pisoni A, Rubbo PA, Richard M, Kremer L, Tonga MMW, Chanda D, Peries M, Vallo R, Eymard-Duvernay S, D'Ottavi M, Kankasa C, de Perre PV, Moles JP, Nagot N. Tuaillon E, et al. Among authors: nagot n. Int J Infect Dis. 2024 Nov;148:107248. doi: 10.1016/j.ijid.2024.107248. Epub 2024 Sep 26. Int J Infect Dis. 2024. PMID: 39341421 Free article.
An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV).
Mennecier A, Sakana BLD, D'Ottavi M, Tassembedo S, Moles JP, Kania D, Taofiki AO, Kadeba FE, Diallo I, Eymard-Duvernay S, Meda N, Mosqueira B, Fao P, Nagot N; PREVENIR-PEV Study Group; Vande Perre P. Mennecier A, et al. Among authors: nagot n. BMC Infect Dis. 2024 Sep 20;24(1):1014. doi: 10.1186/s12879-024-09910-z. BMC Infect Dis. 2024. PMID: 39300364 Free PMC article. Clinical Trial.
Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial.
Goga A, Ramraj T, Naidoo L, Daniels B, Matlou M, Chetty T, Dassaye R, Ngandu NK, Galli L, Reddy T, Seocharan I, Ndlangamandla Q, September Q, Ngcobo N, Reddy M, Cafun-Naidoo T, Woeber K, Jeenarain N, Imamdin R, Maharajh K, Ramjeth A, Bhengu T, Clarence E, Van de Perre P, Tylleskär T, Nagot N, Moles JP, Moore PL, Mkhize NN, Gama L, Dispinseri S, Biswas P, Scarlatti G; PedMAb1 clinical trial team. Goga A, et al. Among authors: nagot n. BMC Infect Dis. 2024 Jul 20;24(1):712. doi: 10.1186/s12879-024-09588-3. BMC Infect Dis. 2024. PMID: 39033300 Free PMC article.
Context-specific estimates of vertical transmission.
Tassembedo S, Traore IT, Ouedraogo AS, Meda N, Van de Perre P, Nagot N, Kirakoya-Samadoulougou F. Tassembedo S, et al. Among authors: nagot n. Lancet HIV. 2024 Jun;11(6):e353. doi: 10.1016/S2352-3018(24)00095-X. Epub 2024 Apr 30. Lancet HIV. 2024. PMID: 38701820 No abstract available.
230 results